Cervical cancer最新文献

{"title":"2022-RA-958-ESGO Invasive stratified mucin-producing intraepithelial lesion (iSMILE) a rare entity of cervical cancer","authors":"Zeineb Zemni, Mohamed Rebei, Sarah Amari, Manel Abbes, Outeyba Belkhayatia, A. Fadhlaoui, M. Kdous, M. Ferchiou","doi":"10.1136/ijgc-2022-esgo.75","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.75","url":null,"abstract":"","PeriodicalId":114847,"journal":{"name":"Cervical cancer","volume":"58 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114187347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"2022-RA-1037-ESGO Effect of alpha-lipoic acid supplementation on regression of low-grade squamous intraepithelial lesions","authors":"Anja Divković, Z. Karasalihović, Adnan Šerak, Emir Trnačević, K. Radić, Nikolina Golub, M. Rajković, I. Stojanović, D. Butorac, D. V. Čepo","doi":"10.1136/ijgc-2022-esgo.83","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.83","url":null,"abstract":"","PeriodicalId":114847,"journal":{"name":"Cervical cancer","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131225130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"2022-RA-438-ESGO A comparison of survival and recurrence pattern of patients presenting locally advanced cervical cancer according to the histological subtype: a monocentric retrospective study","authors":"M. de Cuypere, Clémence Pleyers, J. Hermesse, P. Lovinfosse, K. Delbecque, É. Gonne, A. Kakkos, F. Goffin, F. Kridelka, C. Gennigens","doi":"10.1136/ijgc-2022-esgo.24","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.24","url":null,"abstract":"","PeriodicalId":114847,"journal":{"name":"Cervical cancer","volume":"349 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127010960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"2022-RA-1369-ESGO TRICIN: A phase II trial on the efficacy of topical TRIchloroacetic acid in patients with cervical intraepithelial neoplasia","authors":"R. Schwameis, Julia Ganhoer- Schimboeck, Victoria Laudia Hadjari, L. Hefler, Birgit Bergmeister, Tatjana Kuessel, G. Gittler, Theodora Steindl-Schoenhuber, Christoph Grimm","doi":"10.1136/ijgc-2022-esgo.119","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.119","url":null,"abstract":"","PeriodicalId":114847,"journal":{"name":"Cervical cancer","volume":"33 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128128807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"2022-RA-905-ESGO Mismatch repair deficiency is not applicable as biomarker in cervical cancer, yet MSH-2 has strong prognostic value","authors":"M. C. van den Berg, H. Berg, Thomas Stokowy, E. Hoivik, K. Woie, Hilde Engerud, A. I. Ojesina, Ingfrid Helene Salvesen Haldorsen, B. Bertelsen, J. Trovik, M. K. Halle, C. Krakstad","doi":"10.1136/ijgc-2022-esgo.68","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.68","url":null,"abstract":"2 patients. Ultrastaging enabled to identify additional 7 cases with MAC, 29 MIC, 20 ITC. Of the 82 (12.7%) patients with positive SLN, only 46 (56.1%) cases were detected by standard assessment (83.7% MAC; 25.6% MIC). Additional N1 were identified by ultrastaging, 20 (24.4%) at level 1, 9 (11.0%) at levels 2 – 4, and 6 (7.3%) at level 5 or higher. There was no MAC beyond the first four levels. Abstract 2022-RA-908-ESGO Figure 1 Conclusion Pathological ultrastaging is a key component of the SLN concept in cervical cancer. It enables detection of additional 44% of patients with N1 (MAC, MIC) and almost all (91%) with ITC. The detection of positive SLN directly corre-lates with the intensity of ultrastaging. Four levels should become an international standard, which allows to detect over 90% of N1 (MAC, MIC).","PeriodicalId":114847,"journal":{"name":"Cervical cancer","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123227707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"2022-RA-652-ESGO Non-clipping methods during distal external iliac lymphadenectomy reduce the incidence of lower leg lymphedema in patients with cervical cancer","authors":"Joonshik Yoon, Jiwoo Lee, S. Kim","doi":"10.1136/ijgc-2022-esgo.41","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.41","url":null,"abstract":"","PeriodicalId":114847,"journal":{"name":"Cervical cancer","volume":"125 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115577177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"2022-RA-1071-ESGO Primary treatment and prognostic factors of neuroendocrine carcinoma of the uterine cervix","authors":"Seoyoon Lee, S. I. Kim, H. Lim, Junhwan Kim, Maria Lee, Jae Won Kim","doi":"10.1136/ijgc-2022-esgo.89","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.89","url":null,"abstract":"","PeriodicalId":114847,"journal":{"name":"Cervical cancer","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122702257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"2022-RA-729-ESGO Strengthening of pelvic floor muscles for incontinence in cervical cancer","authors":"Shilpa Bhosale, L. Gurram, S. Chopra, A. Daptardar","doi":"10.1136/ijgc-2022-esgo.53","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.53","url":null,"abstract":"","PeriodicalId":114847,"journal":{"name":"Cervical cancer","volume":"85 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129449968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"2022-RA-1548-ESGO Trial in progress update on ENGOT-cx8/GOG-3024/innovaTV 205: addition of a new cohort using first-line tisotumab vedotin + pembrolizumab + carboplatin ± bevacizumab in recurrent/metastatic cervical cancer","authors":"I. Vergote, M. Mirza, J. Sehouli, D. Lorusso, F. Kose, D. Cibula, A. Westermann, D. Collins, Susana Banerjee, A. Oaknin, I. Soumaoro, Shweta Jain, B. Monk","doi":"10.1136/ijgc-2022-esgo.139","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.139","url":null,"abstract":"","PeriodicalId":114847,"journal":{"name":"Cervical cancer","volume":"500 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125284454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"2022-RA-1301-ESGO The impact of hospital surgical volume on survival in early-stage cervical cancer treated with radical hysterectomy: a sub-analysis of the SCCAN study","authors":"N. Bizzarri, L. Dostálek, Luc Rcw Van Lonkhuijzen, D. Giannarelli, A. Lopez, H. Falconer, D. Querleu, A. Ayhan, Sarah H. Kim, David Isla Ortiz, J. Klat, A. Obermair, F. Landoni, Juliana Rodriguez, R. Manchanda, J. Kosťun, P. Ramirez, M. Meydanlı, D. Odetto, R. Laky, I. Zapardiel, V. Weinberger, R. Reis, L. P. Anchora, K. Amaro, S. Salehi, H. Akıllı, N. Abu-Rustum, R. Salcedo-Hernández, V. Javůrková, C. Mom, G. Scambia, D. Cibula","doi":"10.1136/ijgc-2022-esgo.114","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.114","url":null,"abstract":"2022-RA-1301-ESGO Figure 1 Conclusion Surgical volume represented an independent prognostic factor affecting DFS. Increasing number of RHs performed in each center every year was associated with improved DFS. Performance of at least 18 RHs per year may be considered the target volume of cases for referral centers associated with better DFS. 2022-RA-1302-ESGO ASSOCIATION OF SUVMAX WITH SURVIVAL AND KNOWN PROGNOSTIC FACTORS IN LOCO-REGIONALLY ADVANCED CERVIX CANCER Kailash Narayan, Ming Yin Lin, Srinivas Kondalsamy-Chennakesavan, Rodney Hicks. Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; The University of Queensland Rural Clinical School, Toowoomba, Australia; Melbourne Theranostics Innovation Centre, Melbourne, Australia 10.1136/ijgc-2022-ESGO.115 Introduction/Background The Standardised Uptake Value (SUV) on FDG PET reflects glycolytic metabolism and high values have been shown to be associated with aggressive tumour biology and a poor prognosis in some but not all cancers. The purpose of this study was to evaluate the association of baseline SUVmax with tumour volume, lymph-node involvement and survival in loco-regionally advanced cervix cancer (LRACC) patients. Methodology One hundred fifty-one LRACC patients, treated with curative intent between 1996 and 2014 were retrieved. Patients were classified to FIGO 2018 staging based on histopathology, MRI (for tumour volume and local compartmental spread) and PET (for measuring SUVmax and nodal spread). Association of SUVmax with known prognostic factors such as age, histology, FIGO stage, tumour volume and nodal spread was studied using relevant statistical tests and regression models. Cox proportional hazards model was used to evaluate predictors of relapse-free and overall survival. Results SUVmax of the primary tumour was significantly higher (17.2 vs 13.8, p=0.012) in patients with positive nodes compared to those who were node negative. Similarly, SUVmax was 3.6 units higher in those with tumour volume above the median (34.3cc) compared to those with tumour volume below the median (p=0.007). There was no difference in the distribution of relapses and deaths by quartiles of SUVmax. There was no significant difference in FDG uptake by histology, p=0.2352. While node positivity and tumour volume were independent predictors of relapses, SUVmax was not. Tumour volume was an independent predictor of overall survival in LRACC. Conclusion Prognosis in LRACC depends on the interplay between primary tumour (local control) and nodal disease (regional and distant relapse). SUVmax has limited independent prognostic value in LRACC. The primary role of FDG PET/CT remains detection of nodal and distant metastasis. 2022-RA-1332-ESGO TIMING AND DURATION OF DEFINITIVE RADIATION THERAPY WITH OR WITHOUT CONCURRENT CHEMOTHERAPY FOR FIGO 2018 STAGE IB3 – IVA CERVICAL CANCER IN A TERTIARY REFERRAL HOSPITAL IN THE PHILIPPINES May Bugagao David, Renee Vina G Sicam, Nonette A Cupino. Departmen","PeriodicalId":114847,"journal":{"name":"Cervical cancer","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128817204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}